Jacqualyn A. Fouse, a director at Agios Pharmaceuticals ($AGIO), sold shares on the open market once in the last year, totaling about $194,000, with her most recent sale on April 10, 2025. Her sales rank 8,486th among 11,678 individual insiders, below the average of $8.59 million per seller and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FOUSE JACQUALYN A | Director | A | Common Stock | 203 | $0.00 | 1,097.0000 | 22,080,246 | 22.71% | 0.00% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FOUSE JACQUALYN A | Director | A | Stock Option (Right to Buy) | 366 | $0.00 | 366.0000 | 22,080,246 | 9999.99% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | A | Restricted stock units | 2816 | $0.00 | 2,816.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 2120 | $0.00 | 151,340.0000 | 74,103,192,000 | 1.42% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Restricted stock units | 2120 | $0.00 | 0.0000 | 74,103,192,000 | 100.00% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | A | Stock options (right to buy) | 15768 | $0.00 | 15,768.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | FOUSE JACQUALYN A | Director | A | Common Stock | 2518 | $0.00 | 19,326.0000 | 210,530,000 | 14.98% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | FOUSE JACQUALYN A | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| April 10, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | S | Common stock | 7497 | $25.90 | 149,220.0000 | 74,103,192,000 | 4.78% | 0.00% |
| April 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 15933 | $0.00 | 156,717.0000 | 74,103,192,000 | 11.32% | 0.00% |
| April 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Restricted stock units | 15933 | $0.00 | 0.0000 | 74,103,192,000 | 100.00% | 0.00% |
| March 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FOUSE JACQUALYN A | Director | A | Stock Option (Right to Buy) | 1579 | $0.00 | 1,579.0000 | 22,080,246 | 9999.99% | 0.01% |
| March 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FOUSE JACQUALYN A | Director | A | Common Stock | 894 | $0.00 | 894.0000 | 22,080,246 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | A | Restricted stock units | 2120 | $0.00 | 2,120.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | A | Stock options (right to buy) | 11774 | $0.00 | 11,774.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 3388 | $0.00 | 140,784.0000 | 72,967,922,000 | 2.47% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Restricted stock units | 3388 | $0.00 | 0.0000 | 72,967,922,000 | 100.00% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | FOUSE JACQUALYN A | Director | A | Common Stock | 2830 | $0.00 | 16,808.0000 | 225,928,000 | 20.25% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | FOUSE JACQUALYN A | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| April 8, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 15934 | $0.00 | 145,187.0000 | 72,967,922,000 | 12.33% | 0.00% |
| April 10, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | S | Common stock | 7791 | $27.55 | 137,396.0000 | 72,967,922,000 | 5.37% | 0.00% |
| April 8, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Restricted stock units | 15934 | $0.00 | 15,933.0000 | 72,967,922,000 | 50.00% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 23900 | $0.00 | 139,975.0000 | 72,161,489,000 | 20.59% | 0.00% |
| Jan. 24, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | S | Common stock | 10722 | $21.64 | 129,253.0000 | 72,161,489,000 | 7.66% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Performance share units | 23900 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 17500 | $0.00 | 124,466.0000 | 72,161,489,000 | 16.36% | 0.00% |
| Jan. 9, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | S | Common stock | 8391 | $22.99 | 116,075.0000 | 72,161,489,000 | 6.74% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Performance share units | 17500 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 23900 | $0.00 | 117,684.0000 | 71,256,118 | 25.48% | 0.03% |
| June 30, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | S | Common stock | 10718 | $28.36 | 106,966.0000 | 71,256,118 | 9.11% | 0.02% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Performance share units | 23900 | $0.00 | 23,900.0000 | 71,256,118 | 50.00% | 0.03% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | A | Restricted stock units | 3388 | $0.00 | 3,388.0000 | 71,256,118 | 9999.99% | 0.00% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | A | Stock options (right to buy) | 18958 | $0.00 | 18,958.0000 | 71,256,118 | 9999.99% | 0.03% |
| April 8, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 15933 | $0.00 | 98,515.0000 | 71,256,118 | 19.29% | 0.02% |
| April 12, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | F | Common stock | 4731 | $21.35 | 93,784.0000 | 71,256,118 | 4.80% | 0.01% |
| April 8, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Restricted stock units | 15933 | $0.00 | 31,867.0000 | 71,256,118 | 33.33% | 0.02% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Common stock | 11333 | $0.00 | 86,230.0000 | 71,256,118 | 15.13% | 0.02% |
| Feb. 16, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | F | Common stock | 3648 | $28.91 | 82,582.0000 | 71,256,118 | 4.23% | 0.01% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | FOUSE JACQUALYN A | Director | M | Restricted stock units | 11333 | $0.00 | 0.0000 | 71,256,118 | 100.00% | 0.02% |